Literature DB >> 29683663

Reactivity and Specificity of RNase T1, RNase A, and RNase H toward Oligonucleotides of RNA Containing 8-Oxo-7,8-dihydroguanosine.

Cassandra Herbert1, Yannick Kokouvi Dzowo1, Anthony Urban1, Courtney N Kiggins1, Marino J E Resendiz1.   

Abstract

Understanding how oxidatively damaged RNA interacts with ribonucleases is important because of its proposed role in the development and progression of disease. Thus, understanding structural aspects of RNA containing lesions generated under oxidative stress, as well as its interactions with other biopolymers, is fundamental. We explored the reactivity of RNase A, RNase T1, and RNase H toward oligonucleotides of RNA containing 8-oxo-7,8-dihydroguanosine (8oxoG). This is the first example that addresses this relationship and will be useful for understanding (1) how these RNases can be used to characterize the structural impact that this lesion has on RNA and (2) how oxidatively modified RNA may be handled intracellularly. 8-OxoG was incorporated into 10-16-mers of RNA, and its reactivity with each ribonuclease was assessed via electrophoretic analyses, circular dichroism, and the use of other C8-purine-modified analogues (8-bromoguanosine, 8-methoxyguanosine, and 8-oxoadenosine). RNase T1 does not recognize sites containing 8-oxoG, while RNase A recognizes and cleaves RNA at positions containing this lesion while differentiating if it is involved in H-bonding. The selectivity of RNase A followed the order C > 8-oxoG ≈ U. In addition, isothermal titration calorimetry showed that an 8-oxoG-C3'-methylphosphate derivative can inhibit RNase A activity. Cleavage patterns obtained from RNase H displayed changes in reactivity in a sequence- and concentration-dependent manner and displayed recognition at sites containing the modification in some cases. These data will aid in understanding how this modification affects reactivity with ribonucleases and will enable the characterization of global and local structural changes in oxidatively damaged RNA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29683663     DOI: 10.1021/acs.biochem.8b00277

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  RNA from a simple-tandem repeat is required for sperm maturation and male fertility in Drosophila melanogaster.

Authors:  Wilbur Kyle Mills; Yuh Chwen G Lee; Antje M Kochendoerfer; Elaine M Dunleavy; Gary H Karpen
Journal:  Elife       Date:  2019-11-05       Impact factor: 8.140

2.  7,8-Dihydro-8-oxoguanosine Lesions Inhibit the Theophylline Aptamer or Change Its Selectivity.

Authors:  Courtney Kiggins; Austin Skinner; Marino J E Resendiz
Journal:  Chembiochem       Date:  2020-01-30       Impact factor: 3.164

3.  Processing of RNA Containing 8-Oxo-7,8-Dihydroguanosine (8-oxoG) by the Exoribonuclease Xrn-1.

Authors:  Cheyenne N Phillips; Shawn Schowe; Conner J Langeberg; Namoos Siddique; Erich G Chapman; Marino J E Resendiz
Journal:  Front Mol Biosci       Date:  2021-11-15

4.  Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.

Authors:  Mahgol Behnia; Alan Baer; Andrew M Skidmore; Caitlin W Lehman; Nicole Bracci; Kylene Kehn-Hall; Steven B Bradfute
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.818

5.  Translesion synthesis by AMV, HIV, and MMLVreverse transcriptases using RNA templates containing inosine, guanosine, and their 8-oxo-7,8-dihydropurine derivatives.

Authors:  Madeline M Glennon; Austin Skinner; Mara Krutsinger; Marino J E Resendiz
Journal:  PLoS One       Date:  2020-08-28       Impact factor: 3.240

6.  Experimental and theoretical rationalization for the base pairing abilities of inosine, guanosine, adenosine, and their corresponding 8-oxo-7,8-dihydropurine, and 8-bromopurine analogues within A-form duplexes of RNA.

Authors:  Austin Skinner; Chou-Hsun Yang; Kazuki Hincks; Haobin Wang; Marino J E Resendiz
Journal:  Biopolymers       Date:  2020-11-20       Impact factor: 2.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.